SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : A Biotech Bash - Recs and Wrecks
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: r. peter Dale who wrote ()8/28/1997 7:50:00 AM
From: r. peter Dale   of 171
 
Miljenko and Rick: y'all are great resources - much obliged.

One minor, but ongoing, suggestion. Lets try to keep a balance between a listing of companies involved in certain fields and the data available to back up their claims. Kudos to Miljenko for the links. That is, if you mention that a company has developed XYZ drug, please provide some data or literature refs to verify and at least a bare outline of your understanding of the mechanism of action. Otherwise its difficult to place a framework on the direct competitors in a broad field simply by knowing the names of the companies or the individual scientists.

Also, Rick's mention of side effects with BBIOY's and Miljenko's noting of ambiguous results of certain drugs (shocking) underscores the importance of always including the dirty underside of pharmaceuticals in these posts. The red flag in Miljenko's post - in my experience - was Genistein, a compound advertised as a protein tyrosine kinase inhibitor but which displays significant anti-protein kinase C activity at relatively low concentrations in vitro.

Repost of an earlier question: Do y'all have any advice on how to avoid getting burned by a company whose product fails at Phase III of clinical trials?

Best wishes,
Peter

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News